# Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

> **NCT05839535** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BEHAVIORAL:** BDJ
- **DEVICE:** tDCS
- **DEVICE:** sham tDCS
- **OTHER:** exercise

## Key facts

- **NCT ID:** NCT05839535
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-05
- **Primary completion:** 2028-03-30
- **Final completion:** 2028-08-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839535, "Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05839535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*